1. Amadori, D, Frassineti, GL, Zoli, W, Milandri, C, Tienghi, A, Ravaioli, A, Gentile, A & Salzano, E (1996) A phase I/II study of sequential doxorubicin and paclitaxel treatment of advanced breast cancer. Semin Oncol 23 (suppl 11) S16–S22.
2. Amadori, D, Frassineti, GL, De Matteis, A, Mustacchi, G, Santoro, A, Cariello, S, Ferrari, M, Nascinben, O, Nanni, O, Lombardi, A, Scarpi, E & Zoli, W (1998) Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: results from a multicenter prospective randomized trial. Breast Cancer Res Treat 49: 209–217.
3. Belani, CP (1998) Single agents in the second-line treatment of non-small cell lung cancer. Semin Oncol 25 (suppl 8) S10–S14.
4. Boyer, MJ (1998) New chemotherapeutic agents in the treatment of non-small cell lung cancer: the Australian experience. Chest 113 (suppl 1) S24–S27.
5. Crino, L, Mosconi, AM, Scagliotti, G, De Marinis, F, Darwish, S, Calandri, C, Adamo, V, Scarcella, L, Pucci, F & Tonato, M (1997) Salvage therapy with gemcitabine (GEM) in pretreated, advanced non-small cell lung cancer (NSCLC). Proc Annu Meet Soc Clin Oncol 16: 1603